{
    "ticker": "FOACW",
    "name": "Fortress Biotech, Inc.",
    "description": "Fortress Biotech, Inc. is a biopharmaceutical company dedicated to advancing innovative therapies for patients with unmet medical needs. Founded in 2016, Fortress focuses on the development and commercialization of novel therapeutics in various therapeutic areas, including oncology, immunology, and rare diseases. The company operates through its subsidiaries and collaborations, leveraging a diverse pipeline of product candidates at various stages of development. Fortress Biotech is committed to addressing significant medical challenges by harnessing cutting-edge science and technology to bring new treatment options to patients. The company's strategy includes identifying and acquiring promising drug candidates, optimizing their development, and facilitating successful market entry. In addition to its clinical initiatives, Fortress emphasizes the importance of building strategic partnerships with other biotech firms, research institutions, and healthcare providers to enhance its research capabilities and expedite the delivery of its products to the market. With a strong focus on innovation, Fortress Biotech aims to become a leader in the biopharmaceutical industry by improving patient outcomes and transforming the landscape of healthcare.",
    "industry": [
        "Biopharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "New York, New York, USA",
    "founded": "2016",
    "website": "https://www.fortressbiotech.com",
    "ceo": "L. Patrick Gage",
    "social_media": {
        "twitter": "https://twitter.com/fortressbiotech",
        "linkedin": "https://www.linkedin.com/company/fortress-biotech/"
    },
    "investor_relations": "https://ir.fortressbiotech.com",
    "key_executives": [
        {
            "name": "L. Patrick Gage",
            "position": "CEO"
        },
        {
            "name": "Dr. William K. H. Lee",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Oncology",
            "products": [
                "Medi-6383",
                "Medi-5781"
            ]
        },
        {
            "category": "Immunology",
            "products": [
                "Medi-4981"
            ]
        }
    ],
    "seo": {
        "meta_title": "Fortress Biotech, Inc. | Innovative Biopharmaceutical Solutions",
        "meta_description": "Explore Fortress Biotech, Inc., a leader in biopharmaceutical innovation. Learn about their mission to develop novel therapies for patients with unmet medical needs.",
        "keywords": [
            "Fortress Biotech",
            "Biopharmaceuticals",
            "Innovative Therapies",
            "Oncology",
            "Immunology",
            "Healthcare"
        ]
    },
    "faq": [
        {
            "question": "What does Fortress Biotech do?",
            "answer": "Fortress Biotech focuses on developing innovative therapies for unmet medical needs in oncology, immunology, and rare diseases."
        },
        {
            "question": "Who is the CEO of Fortress Biotech?",
            "answer": "L. Patrick Gage is the CEO of Fortress Biotech, Inc."
        },
        {
            "question": "Where is Fortress Biotech headquartered?",
            "answer": "Fortress Biotech is headquartered in New York, New York, USA."
        },
        {
            "question": "What are Fortress Biotech's main therapeutic areas?",
            "answer": "Fortress Biotech primarily focuses on oncology, immunology, and rare diseases."
        },
        {
            "question": "When was Fortress Biotech founded?",
            "answer": "Fortress Biotech was founded in 2016."
        }
    ],
    "competitors": [
        "AMGN",
        "REGN",
        "GILD",
        "VRTX"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "ABBV",
        "BMY"
    ]
}